Purchase Order 36C77020P0749
Award Date 6/23/20
Potential Completion Date 6/30/20
Potential Value $654K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract was awarded to Priority Healthcare Distribution Inc., through its Curascript SD Specialty Distribution division, by the Department of Veterans Affairs Veterans Health Administration for the delivery of the pharmaceutical DROXIDOPA. The firm-fixed-price purchase order has a potential value of $144,317.80 and a completion date of December 7, 2018. No set-aside was used for this award. As a prime contractor, Priority Healthcare Distribution Inc. has a history of providing...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $577,464 fixed-price purchase order to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution, to deliver DROXIDOPA in 100mg, 200mg, and 300mg dosages. As the prime contractor, Curascript SD Specialty Distribution will supply the drug to Hines, Illinois for distribution in support of VHA programs. No subcontractors or set aside designations...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $645,568.20 purchase order contract to Priority Healthcare Distribution Inc. Curascript SD Specialty Distribution Division for pharmaceuticals. The contract has a period of performance from March 26, 2020 to April 3, 2020 and utilizes a firm fixed price pricing structure. The place of performance is Lake Mary, Florida. No additional details were provided regarding subcontractors...
- The Department of Veterans Affairs Veterans Health Administration awarded a $509,543 purchase order to Priority Healthcare Distribution Inc. Curascript SD Specialty Distribution Division for pharmaceuticals. The contract has a period of performance from January 10, 2020 to January 17, 2020. As a prime contractor, Curascript SD Specialty Distribution will deliver pharmaceutical products to support the VA-VHA's Veterans Integrated Service Network 12 located in Lake Mary, Florida under this...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Priority Healthcare Distribution Inc. through its Curascript SD Specialty Distribution division. The $175,587.60 firm fixed price purchase order is for the supply of a single line item pharmaceutical product. The contract has no set-aside designation and will be performed at Priority Healthcare's facility in Lake Mary, Florida. As a prime contractor, Priority Healthcare...
- This federal contract award to Priority Healthcare Distribution Inc., through its Curascript SD Specialty Distribution division, provides pharmaceutical products and distribution services to support patient care programs at various U.S. government agencies. The $121,572.80 firm fixed price contract was issued by the Department of Veterans Affairs Veterans Health Administration, and does not have a set-aside designation. The contract delivers a range of pharmaceuticals, including cardiovascular...
- This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Priority Healthcare Distribution Inc. through its Curascript SD Specialty Distribution division. The $188,484.48 firm fixed price purchase order is for the delivery of pharmaceuticals to VA facilities, with a completion date of August 20, 2018. As a for-profit prime contractor, Priority Healthcare Distribution has a history of federal contracts to supply medications and specialty...
- Priority Healthcare Distribution Inc., operating through its Curascript SD Specialty Distribution division, has been awarded a firm fixed-price purchase order valued at $15,746.12 by Veterans Integrated Service Network 2, a civilian agency within the Department of Veterans Affairs. The contract, awarded on January 22, 2026, with an ultimate completion date of April 22, 2026, covers the supply of Tyvaso, a specialty pharmaceutical used to treat pulmonary arterial hypertension through inhalation...
- This federal contract award, valued at $75,820.95, was issued by the Veterans Integrated Service Network 7 (VISN7), a civilian agency under the U.S. Department of Veterans Affairs, to the prime contractor Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution. The contract is a firm fixed-price purchase order for the delivery of AUTHAR GEL, a specialty pharmaceutical product, with a period of performance ending on October 15, 2018. The contract does not...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,920.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the drug DROXIDOPA 100 MG CAPSULE. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $653,893.90 purchase order to Priority Healthcare Distribution Inc. Curascript SD Specialty Distribution Division for the drug DROXIDOPA. The single award firm fixed price contract runs from June 23, 2020 to June 30, 2020 for distribution from Lake Mary, Florida. As the VA-VHA works to provide quality healthcare services to veterans, this contract supports their goal of ensuring access to necessary pharmaceuticals. No set aside designation or subcontractors were indicated.
Generated 12/25/23, 3:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $653.9k | 6/23/20 |